rel="nofollow" href="#ulink_ba6872aa-d336-5a53-8dd0-7068367a00a2">104ShI X, Garry DJ: Muscle stem cells in development, regeneration, and disease. Genes Dev 2006;20:1692–1708.
105Christov C, Chretien F, Abou-Khalil R, Bassez G, Vallet G, Authier FJ, et al: Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007;18:1397–1409.
106Mounier R, Chretien F, Chazaud B: Blood vessels and the satellite cell niche. Curr Top Dev Biol 2011;96:121–138.
107Ceafalan LC, Popescu BO, Hinescu ME: Cellular players in skeletal muscle regeneration. Bio Med Res Int 2014;2014:957014.
108Elsafadi M, Manikandan M, Dawud RA, Alajez NM, Hamam R, Alfayez M, et al: Transgelin is a TGFβ-inducible gene that regulates osteoblastic and adipogenic differentiation of human skeletal stem cells through actin cytoskeleston organization. Cell Death Dis 2016;7:e2321.
109Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA: Cellular dynamics in the muscle satellite cell niche. EMBO Rep 2013;14:1062–1072.
110Pevsner-Fischer M, Morad V, Cohen-Sfady M, Russso-Noori L, Zanin-Zhorov A, Cohen IR, et al: Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007;109:1422–1432.
111Qi C, Xiaofeng X, Xiaoguang W: Effects of Toll-Like Receptors 3 and 4 in the Osteogenesis of Stem Cells. Stem Cell Int 2014;2014:917168.
112Delarosa O, Dalemans W, Lombardo E: Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol 2012;3:182.
113Shirjang S, Mansoori B, Solali S, Hagh MF, Shamsasenjan K: Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review. Cell Immunol 2017;315:1–10.
114Alvarado AG, Lathia JD: Taking a toll on self-renewal: TLR-mediated innate immune signaling in stem cells. Trends Neurosci 2016;39:463–471.
115Ingber DE: Mechanobiology and diseases of mechanotransduction. Ann Med 2003;35:564–577.
116Orr AW, Helmke BP, Blackman BR, Schwartz MA: Mechanisms of Mechanotransduction. Dev Cell 2006;10:11–20.
117Huang H, Kamm RD, Lee RT: Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am J Physiol 2004;287:C1–C11.
118Chen CS: Mechanotransduction – a field pulling together? J Cell Sci 2008;121:3285–3292.
119Chiquet M, Gelman L, Lutz R, Maier S: From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta 2009;1793:911–920.
120Jaalouk DE, Lammerding J: Mechantransduction gone awry. Nat Rev Mol Cell Biol 2009;10:63–73.
121Paluch EK, Nelson CM, Biais N, Fabry B, Moller J, Pruitt BL, et al: Mechanotransduction: use the force(s). BMC Biol 2015;4:47.
122Chopra A, Murray ME, Byfield FJ, Mendez MG, Halleluyan R, Restle DJ, et al: Augmentation of integrin-mediated mechanotransduction by hyaluronic acid. Biomaterials 2014;35:71–82.
123Schwartz MA: Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2010;2:e005066.
124Sun Z, Guo SS, Fassler R: Integrin-mediated mechanotransduction. J Cell Biol 2016;215:445–456.
125du Roure O, Saez A, Buguin A, Austin RH, Chavrier P, Silberzan P, Ladoux B: Force mapping in epithelial cell migration. Proc Natl Acad Sci USA 2005;102:2390–2395.
126Engler AJ, Sen S, Sweeney HL, Discher DE: Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677–689.
127Vogel V, Sheetz MP: Cell fate regulation by coupling mechanical cycles to biochemical signaling pathways. Curr Opin Cell Biol 2009;21:38–46.
128Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231–245.
129You L, Cowin SC, Schaffler MB, Weinbaum S: A model for strain amplification in the actin cytoskeleton of osteocytes due to fluid drag on pericellular matrix. J Biomech 2001;34:1375–1386.
130Alenghat FJ, Nauli SM, Kolb R, Zhou J, Ingber DE: Global cytoskeletal control of mechanotransduction in kidney epithelial cells. Exp Cell Res 2004;301:23–30.
131Han Y, Cowin SC, Schaffler MB, Weinbaum S: Mechanotransduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci U S A 2004;101:16689–16694.
132Hausner T, Nogradi A: The Use of Shock Waves in Peripheral Nerve Regeneration: New Perspectives?; in Guena S, Perroteau I, Tos P, Battiston B (eds): International Review of Neurobiology: Tissue Engineering of The Peripheral Nerve: Biomaterials and Physical Therapy (vol 109). London, Academic Press2013, p 88.
133Raabe O, Shell K, Goessl A, Crispens C, Delhasse Y, Eva A: Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells 2013;2:62–773.
134Leone L, Raffa S, Vetrano M, Ranieri D, Malisan F, Scrofani C, et al: Extracorporeal shock wave treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs).Oncotarget 2016;7:6410–6423.
135Trompetto C, Avanzino L, Bove M, Marinelli L, Molfetta L, Trentini R, et al: External shock waves therapy in dystonia: preliminary results. Eur J Neurol 2009;16:517–521.
136Mori L, Marinelli L, Pelosin E, Curra A, Molfetta L, Abbruzzese G, Trompetto C: Shock waves in the treatment of muscle hypertonia and dystonia. Biomed Res Int 2014;2014:637–450.
137Lee JY, Kim SN, Lee IS, Jung H, Lee KS, Koh SE: Effects of extracorporeal shock wave therapy on spasticity in patients after brain injury: a meta-analysis. J Phy Ther Sci 2014;26:1641–1647.
138Hala A, Gawad A, Karim AEA, Mohammad H: Shock wave therapy for spastic plantar flexor muscles in hemiplegic cerebral palsy children. Egyptian J Human Gen 2015;16:269–275.
139Mirea A, Onose G, Padure L, Rosulescu E: Extracorporeal Shockwave Therapy (ESWT) benefits in spastic children with Cerebral Palsy (CP). J Med Life 2014;7:127–132.
140Park DS, Kwon DR, Park GY, Lee MY: Therapeutic effect of extracorporeal shock wave therapy according to treatment session on gastrocnemius muscle spasticity in children with spastic cerebral palsy: a pilot study. Ann Rehabil Med 2015;39:914–921.
141Vincent KC, d’Agostino MC, Poratt D, Walker M: Utilisation of eswt to restore peripheral
